Colorectal Cancer Genetic Variants Are Also Associated with Serrated Polyposis Syndrome Susceptibility
View/ Open
Date
2020-10Author
Arnau Collell, Coral
Soares de Lima, Yasmin
Díaz Gay, Marcos
Muñoz, Jenifer
Carballal, Sabela
Bonjoch, Laia
Moreira, Leticia
Lozano, Juan José
Ocaña, Teresa
Cuatrecasas, Miriam
Díaz de Bustamante, Aranzazu
Castells, Antoni
Capella, Gabriel
Cubiella, Joaquín
Rodríguez Alcalde, Daniel
Balaguer, Francesc
Ruiz Ponte, Clara
Valle, Laura
Moreno, Víctor
Castellví Bel, Sergi
Metadata
Show full item record
Journal Of Medical Genetics 57(10) : 677-682 (2020)
Abstract
Background Serrated polyposis syndrome (SPS) is a clinical entity characterised by large and/ormultiple serrated polyps throughout the colon and increased risk for colorectal cancer (CRC). The basis for SPS genetic predisposition is largely unknown. Common, low-penetrance genetic variants have been consistently associated with CRC susceptibility, however, their role in SPS genetic predisposition has not been yet explored. Objective The aim of this study was to evaluate if common, low-penetrance genetic variants for CRC risk are also implicated in SPS genetic susceptibility. Methods A case-control study was performed in 219 SPS patients and 548 asymptomatic controls analysing 65 CRC susceptibility variants. A risk prediction model for SPS predisposition was developed. Results Statistically significant associations with SPS were found for seven genetic variants (rs4779584-GREM1, rs16892766-EIF3H, rs3217810-CCND2, rs992157-PNKD1/TMBIM1, rs704017-ZMIZ1, rs11196172-TCF7L2, rs6061231-LAMA5). TheGREM1risk allele was remarkably over-represented in SPS cases compared with controls (OR=1.573, 1.21-2.04, p value=0.0006). A fourfold increase in SPS risk was observed when comparing subjects within the highest decile of variants (>= 65) with those in the first decile (<= 50). Conclusions Genetic variants for CRC risk are also involved in SPS susceptibility, being the most relevant ones rs4779584-GREM1, rs16892766-EIF3Hand rs3217810-CCND2.